Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
10.15
-0.02 (-0.20%)
Mar 24, 2026, 1:33 PM EDT - Market open
Design Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$15.25
Upside
+50.25%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +47.78% | Mar 16, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $13 → $14 | Buy | Maintains | $13 → $14 | +37.93% | Mar 10, 2026 |
| Oppenheimer | Oppenheimer | Buy Initiates $18 | Buy | Initiates | $18 | +77.34% | Jan 7, 2026 |
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades $7 → $14 | Hold → Buy | Upgrades | $7 → $14 | +37.93% | Dec 3, 2025 |
| RBC Capital | RBC Capital | Hold → Buy Upgrades $6 → $13 | Hold → Buy | Upgrades | $6 → $13 | +28.08% | Nov 20, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $5 → $6 | Hold | Maintains | $5 → $6 | -40.89% | Nov 6, 2025 |
| RBC Capital | RBC Capital | Hold Reiterates $4 | Hold | Reiterates | $4 | -60.59% | Aug 6, 2024 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $6 → $12 | Hold → Buy | Upgrades | $6 → $12 | +18.23% | May 7, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $4 | Hold | Reiterates | $4 | -60.59% | Mar 20, 2024 |
| Wedbush | Wedbush | Hold Reiterates $5 | Hold | Reiterates | $5 | -50.74% | Mar 20, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $7 → $4 | Hold | Maintains | $7 → $4 | -60.59% | Nov 14, 2023 |
| Wedbush | Wedbush | Buy → Hold Downgrades $6 | Buy → Hold | Downgrades | $6 | -40.89% | Aug 15, 2023 |
| SVB Leerink | SVB Leerink | Buy → Hold Downgrades $6 | Buy → Hold | Downgrades | $6 | -40.89% | Aug 15, 2023 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $23 → $7 | Buy → Hold | Downgrades | $23 → $7 | -31.03% | Aug 15, 2023 |
| RBC Capital | RBC Capital | Buy Maintains $24 → $23 | Buy | Maintains | $24 → $23 | +126.60% | May 10, 2023 |
| Wedbush | Wedbush | Buy Maintains $20 → $19 | Buy | Maintains | $20 → $19 | +87.19% | May 10, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.